Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD.

× No keyword cloud information.

11 in total

1. CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.

Authors: Kylie A Alexander; Ryan Flynn; Katie E Lineburg; Rachel D Kuns; Bianca E Teal; Stuart D Olver; Mary Lor; Neil C Raffelt; Motoko Koyama; Lucie Leveque; Laetitia Le Texier; Michelle Melino; Kate A Markey; Antiopi Varelias; Christian Engwerda; Jonathan S Serody; Baptiste Janela; Florent Ginhoux; Andrew D Clouston; Bruce R Blazar; Geoffrey R Hill; Kelli P A MacDonald
Journal: J Clin Invest Date: 2014-08-26 Impact factor: 14.808

2. Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions.

Authors: C Phipps; M T Lupo-Stanghellini; M E D Flowers
Journal: Bone Marrow Transplant Date: 2013-09-30 Impact factor: 5.483

Review 3. Therapeutic benefits targeting B-cells in chronic graft-versus-host disease.

Authors: Hideki Nakasone; Bita Sahaf; David B Miklos
Journal: Int J Hematol Date: 2015-03-27 Impact factor: 2.490

4. Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.

Authors: Kristin Baird; Leora E Comis; Galen O Joe; Seth M Steinberg; Fran T Hakim; Jeremy J Rose; Sandra A Mitchell; Steven Z Pavletic; William D Figg; Lawrence Yao; Kathleen C Flanders; Naoko Takebe; Stefanie Sarantopoulos; Susan Booher; Edward W Cowen
Journal: Biol Blood Marrow Transplant Date: 2015-03-12 Impact factor: 5.742

5. Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis.

Authors: Fevzi F Yalniz; Mohammad H Murad; Stephanie J Lee; Steven Z Pavletic; Nandita Khera; Nilay D Shah; Shahrukh K Hashmi
Journal: Biol Blood Marrow Transplant Date: 2018-03-14 Impact factor: 5.742

Review 6. Classification systems for chronic graft-versus-host disease.

Authors: Stephanie J Lee
Journal: Blood Date: 2016-11-07 Impact factor: 22.113

7. Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice.

Authors: Hua Jin; Xiong Ni; Ruishu Deng; Qingxiao Song; James Young; Kaniel Cassady; Mingfeng Zhang; Stephen Forman; Paul J Martin; Qifa Liu; Defu Zeng
Journal: Blood Date: 2016-02-16 Impact factor: 22.113

Review 8. Current issues in chronic graft-versus-host disease.

Authors: Gérard Socié; Jerome Ritz
Journal: Blood Date: 2014-06-09 Impact factor: 22.113

9. Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients.

Authors: S Thiant; M M Moutuou; P Laflamme; R Sidi Boumedine; D M Leboeuf; L Busque; J Roy; M Guimond
Journal: Blood Cancer J Date: 2017-04-07 Impact factor: 11.037

10. Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease.

Authors: Ludovic Belle; Gilles Fransolet; Joan Somja; Marilène Binsfeld; Philippe Delvenne; Pierre Drion; Muriel Hannon; Yves Beguin; Grégory Ehx; Frédéric Baron
Journal: PLoS One Date: 2016-12-12 Impact factor: 3.240